🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was an international, multi-center, randomized, double-blind, pl...
Status
Completed
Location
University of Alabama-Birmingham
Start Date
2006-10
Trial ID
NCT00325442
Treatments Being Tested
This study was an international, multicenter, randomized (2:1 active:placeb...
Status
Completed
Location
University of Alabama-Birmingham
Start Date
2006-10
Trial ID
NCT00325403
Treatments Being Tested
This study will evaluate the effect of treprostinil diethanolamine (UT-15C)...
Status
Completed
Location
University of Alabama - Arthritis Clinical Intervention Program
Start Date
2009-05
Trial ID
NCT00775463
Treatments Being Tested
Raynaud's phenomenon is a condition where the blood vessels in participants...
Status
Recruiting
Location
Brigham and Women's Hospital
Start Date
2025-10-15
Trial ID
NCT07112183
Treatments Being Tested
This study provided/continued to provide oral treprostinil (UT-15C SR; trep...
Status
Completed
Location
The Kirklin Clinic
Start Date
2007-01-16
Trial ID
NCT01027949
Treatments Being Tested
This study will compare the bioavailability and pharmacokinetics of the 0.5...
Status
Completed
Location
PPD Development
Start Date
2010-07
Trial ID
NCT01153386
Treatments Being Tested
This was an open-label study to evaluate the safety of continued therapy wi...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2018-01-30
Trial ID
NCT03043651
Treatments Being Tested
This is a multicenter, randomized (2:1 oral treprostinil: placebo), double-...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-10
Trial ID
NCT02999906
Treatments Being Tested
This study will assess the pharmacokinetic and safety profile of treprostin...
Status
Completed
Location
Johns Hopkins Scleroderma Center
Start Date
2008-12
Trial ID
NCT00848939
Treatments Being Tested